RxSight Stock Tumbles on Reduced 2026 Sales Guidance

By EC Assets · Published 7 July 2026

RxSight stock experienced a downturn following the company's release of updated financial projections. The firm revised its sales guidance for the year 2026. This adjustment likely impacted investor sentiment. This article is intended for informational purposes only. It does not constitute investment advice.